The role of T cells in vascular aging, hypertension, and atherosclerosis
Theodore M DeConne1, David J Buckley2, Daniel W Trott2
1Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, United States.
Insights
T lymphocytes (T cells) significantly impact vascular function during aging and in cardiovascular diseases. Targeting T cells may offer new therapeutic strategies to combat vascular dysfunction and related conditions.
Area of Science:
- Cardiovascular Science
- Immunology
- Aging Research
Background:
- Vascular dysfunction is a major risk factor for cardiovascular and cerebrovascular diseases (CVDs), leading causes of global mortality.
- T lymphocytes (T cells) play a critical role in modulating vascular function, particularly in aging and CVDs.
- T cells influence vascular health through inflammatory cytokines and reactive oxygen species, affecting vasoprotective molecules.
Purpose of the Study:
- To review the multifaceted role of T cells in vascular function across different conditions.
- To examine the impact of T cells in aging, hypertension, and atherosclerosis.
- To discuss the potential of T-cell-targeted therapies for vascular dysfunction.
Main Methods:
- Literature review synthesizing findings from animal and human studies.
- Analysis of T cell involvement in primary aging and various cardiovascular disease models.
- Exploration of existing and potential therapeutic interventions targeting T cells.
Main Results:
- T cells are key modulators of vascular function in aging, hypertension, and atherosclerosis.
- T cell-mediated inflammation and oxidative stress contribute to vascular dysfunction.
- Evidence suggests T cells influence vasoprotective mechanisms.
Conclusions:
- T cells are integral to vascular health and dysfunction.
- Targeting T cells presents a promising therapeutic avenue for preventing or reversing vascular dysfunction.
- Further research into T-cell-targeted therapeutics could mitigate CVD morbidity and mortality.
Abstract:
Vascular dysfunction has emerged as a significant risk factor for the development of cardio- and cerebrovascular diseases (CVDs), which are currently the leading cause of morbidity and mortality worldwide. T lymphocytes (T cells) have been shown to be important modulators of vascular function in primary aging and CVDs, likely by producing inflammatory cytokines and reactive oxygen species that influence vasoprotective molecules. This review summarizes the role of T cells on vascular function in aging, hypertension, and atherosclerosis in animals and humans, and discusses potential T-cell targeted therapeutics to prevent, delay, or reverse vascular dysfunction.
More Related Videos
10:16Visualizing Leukocyte Rolling and Adhesion in Angiotensin II-Infused Mice: Techniques and Pitfalls
Published on: January 4, 2018
08:41Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
Related Concept Videos
Hypertension II: Pathophysiology
Atherosclerosis I: Introduction
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Regulation of Angiogenesis and Blood Supply
Atherosclerosis II: Clinical manifestations and prevention
